Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Scott Lucia

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2015
Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention TrialSarah H Nash, Cathee Till, Xiaoling Song, et al.
Urology|June 12, 2017
The 3DBiopsy Prostate Biopsy System: Preclinical Investigation of a Needle, Actuator, and Specimen Collection Device Allowing Sampling of Individualized Prostate Lengths Between 20 and 60 mmNelson N Stone, Vladimir Mouraviev, David Schechter, et al.
The Journal of Urology|January 18, 2015
Search for Microorganisms in Men with Urologic Chronic Pelvic Pain Syndrome: A Culture-Independent Analysis in the MAPP Research NetworkJ Curtis Nickel, Alisa Stephens, J Richard Landis, et al.
Journal of the National Cancer Institute|April 20, 2006
Assessing prostate cancer risk: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Contemporary Clinical Trials|June 19, 2007
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trialNeil Fleshner, Leonard G Gomella, Michael S Cookson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionM Scott Lucia, Amy K Darke, Phyllis J Goodman, et al.
American Journal of Physiology. Renal Physiology|July 20, 2023
IL-6 mediates the hepatic acute phase response after prerenal azotemia in a clinically defined murine modelKayo Okamura, Sizhao Lu, Zhibin He, et al.
The Prostate|September 2, 2003
Laterally directed biopsies detect more clinically threatening prostate cancer: computer simulated resultsNozomu Kawata, Gary J Miller, E David Crawford, et al.
The Journal of Urology|January 16, 2007
A preliminary study of JM-27: a serum marker that can specifically identify men with symptomatic benign prostatic hyperplasiaGrant W Cannon, Chris Mullins, M Scott Lucia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2015
Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention TrialSarah H Nash, Cathee Till, Xiaoling Song, et al.
Urology|June 12, 2017
The 3DBiopsy Prostate Biopsy System: Preclinical Investigation of a Needle, Actuator, and Specimen Collection Device Allowing Sampling of Individualized Prostate Lengths Between 20 and 60 mmNelson N Stone, Vladimir Mouraviev, David Schechter, et al.
The Journal of Urology|January 18, 2015
Search for Microorganisms in Men with Urologic Chronic Pelvic Pain Syndrome: A Culture-Independent Analysis in the MAPP Research NetworkJ Curtis Nickel, Alisa Stephens, J Richard Landis, et al.
Journal of the National Cancer Institute|April 20, 2006
Assessing prostate cancer risk: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Contemporary Clinical Trials|June 19, 2007
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trialNeil Fleshner, Leonard G Gomella, Michael S Cookson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionM Scott Lucia, Amy K Darke, Phyllis J Goodman, et al.
American Journal of Physiology. Renal Physiology|July 20, 2023
IL-6 mediates the hepatic acute phase response after prerenal azotemia in a clinically defined murine modelKayo Okamura, Sizhao Lu, Zhibin He, et al.
The Prostate|September 2, 2003
Laterally directed biopsies detect more clinically threatening prostate cancer: computer simulated resultsNozomu Kawata, Gary J Miller, E David Crawford, et al.
The Journal of Urology|January 16, 2007
A preliminary study of JM-27: a serum marker that can specifically identify men with symptomatic benign prostatic hyperplasiaGrant W Cannon, Chris Mullins, M Scott Lucia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention TrialIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Pageof 17